4.8 Article

Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.647824

Keywords

SARS-CoV-2; COVID-19; dendritic cell; macrophages; interleukin 6; tumor necrosis factor alpha; TNF-alpha; type I interferon; activation status

Categories

Funding

  1. Bundesministerium fuer Bildung und Forschung (BMBF) through the Deutsches Zentrum fur Luft- und Raumfahrt (DLR) [01KI2077]
  2. Federal State of Baden-Wurttemberg, Germany

Ask authors/readers for more resources

Research indicates that mDC and macrophages are susceptible to SARS-CoV-2 infection, but do not produce the virus and show minimal changes in activation status upon infection. Infected innate immune cells do not produce pro-inflammatory cytokines, suggesting they are unlikely to be the source of the initial wave of cytokines post-SARS-CoV-2 infection.
The exact role of innate immune cells upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their contribution to the formation of the corona virus-induced disease (COVID)-19 associated cytokine storm is not yet fully understood. We show that human in vitro differentiated myeloid dendritic cells (mDC) as well as M1 and M2 macrophages are susceptible to infection with SARS-CoV-2 but are not productively infected. Furthermore, infected mDC, M1-, and M2 macrophages show only slight changes in their activation status. Surprisingly, none of the infected innate immune cells produced the pro-inflammatory cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, or interferon (IFN)-alpha. Moreover, even in co-infection experiments using different stimuli, as well as non-influenza (non-flu) or influenza A (flu) viruses, only very minor IL-6 production was induced. In summary, we conclude that mDC and macrophages are unlikely the source of the first wave of cytokines upon infection with SARS-CoV-2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Individual combinations of danger signals synergistically increase FVIII product immunogenicity

Lilija Miller, Jessica Klemm, Carolin Schmidt, Kay-Martin Hanschmann, Isabelle Bekeredjian-Ding, Zoe Waibler

HAEMOPHILIA (2019)

Article Microbiology

Selective reconstitution of IFN-γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection

Katharina Borst, Sven Flindt, Patrick Blank, Pia-Katharina Larsen, Chintan Chhatbar, Jennifer Skerra, Julia Spanier, Christoph Hirche, Martin Koenig, Tomas Alanentalo, Martin Hafner, Zoe Waibler, Klaus Pfeffer, Veronika Sexl, Gerd Sutter, Werner Mueller, Theresa Graalmann, Ulrich Kalinke

PLOS PATHOGENS (2020)

Review Cell Biology

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis

Yen-Ju Lin, Martina Anzaghe, Stefan Schuelke

CELLS (2020)

Review Biochemistry & Molecular Biology

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies

Patricia Gogesch, Simone Dudek, Ger van Zandbergen, Zoe Waibler, Martina Anzaghe

Summary: Efforts have been made to ensure the safety and efficacy of therapeutic monoclonal antibodies since the approval of the first mAb in 1986. Various cell-based assays have been established to evaluate Fc-mediated effector functions of therapeutic mAbs. Optimization strategies such as point mutations and altered glycosylation patterns have led to the development of next-generation therapeutic mAbs with improved efficacy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biotechnology & Applied Microbiology

Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA viruses

Martina Anzaghe, Stefanie Kronhart, Marc A. Niles, Lena Hoecker, Monica Dominguez, Georg Kochs, Zoe Waibler

Summary: Studies have shown that some negative-strand RNA viruses can induce type I interferon responses in an IFNAR-independent manner, rather than relying on the IFNAR feedback loop.

JOURNAL OF GENERAL VIROLOGY (2021)

Article Cell Biology

Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization

Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, Daniel Todt, Arne Auste, Martina Anzaghe, Andre Goemer, Dylan Postmus, Patricia Gogesch, Marc Niles, Roland Plesker, Csaba Miskey, Michelle Gellhorn Serra, Angele Breithaupt, Cindy Hoerner, Carina Kruip, Rosina Ehmann, Zoltan Ivics, Zoe Waibler, Stephanie Pfaender, Emanuel Wyler, Markus Landthaler, Alexandra Kupke, Geraldine Nouailles, Christine Goffinet, Richard J. P. Brown, Michael D. Muehlebach

Summary: In this study, the potential for vaccine-associated enhanced respiratory disease (VAERD) in COVID-19 was investigated using a severe hamster infection model. Two vaccine candidates were evaluated, one derived from a T helper type 1 (T(H)1)-biased measles vaccine and another comprising a T(H)2-biased, alum-adjuvanted, non-stabilized spike protein. The measles vaccine protected the animals, while the protein lead induced VAERD, which could be alleviated with dexamethasone treatment. Transcriptomic and single-cell RNA sequencing analyses identified the cytokine drivers and cellular contributors involved in VAERD.

CELL REPORTS (2022)

Article Immunology

An Attenuated Strain of Human Cytomegalovirus for the Establishment of a Subviral Particle Vaccine

Steffi Krauter, Nicole Buescher, Eric Braeuchle, Samira Ortega Iannazzo, Inessa Penner, Nadine Kraemer, Patricia Gogesch, Simone Thomas, Marina Kreutz, Mario Dejung, Anja Freiwald, Falk Butter, Zoe Waibler, Bodo Plachter

Summary: This study developed a genetically attenuated seed virus strain TR-VAC of human cytomegalovirus (HCMV), which can produce subviral dense bodies (DB) and retains the capacity to induce neutralizing antibodies and activate immune response, making it a potential candidate for DB vaccine.

VACCINES (2022)

Article Hematology

Complement protein C3a enhances adaptive immune responses towards FVIII products

Eva Ringler, Samira Ortega Iannazzo, Jessica Herzig, Lisa M. Weiss, Martina Anzaghe, Lilija Miller, Zoe Waibler

Summary: The development of factor VIII inhibitors or anti-drug antibodies in the treatment of hemophilia A is a serious complication. The immunological mechanisms underlying this development have not been fully understood, but danger signals associated with events like infection or surgery have been suggested to play a role. Plasma components, present in plasma-derived factor VIII products, were found to mediate T-cell responses, with complement proteins C3a and C5a being critically involved.

HAEMATOLOGICA (2023)

No Data Available